• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.

作者信息

Kunutsor Setor K, Laukkanen Jari A

机构信息

National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead Hospital, Bristol, UK.

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Institute of Clinical Medicine, Department of Medicine, University of Eastern Finland, Kuopio, Finland; Central Finland Health Care District Hospital District, Department of Medicine, Jyväskylä, Finland District, Jyväskylä, Finland.

出版信息

J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.045. Epub 2020 May 28.

DOI:10.1016/j.jinf.2020.05.045
PMID:32474033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7255758/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65f/7255758/cb8e7dd7facc/gr1b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65f/7255758/f449fa07d72a/gr1a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65f/7255758/cb8e7dd7facc/gr1b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65f/7255758/f449fa07d72a/gr1a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65f/7255758/cb8e7dd7facc/gr1b_lrg.jpg

相似文献

1
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.新冠病毒肺炎患者肝损伤标志物与临床结局：一项系统评价与荟萃分析
J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.045. Epub 2020 May 28.
2
The challenge of COVID-19 has accelerated the use of new data-sharing technologies.新冠疫情的挑战加速了新数据共享技术的应用。
Respirology. 2020 Aug;25(8):800-801. doi: 10.1111/resp.13894. Epub 2020 Jul 1.
3
Scientific effort in combating COVID-19 in obstetrics and gynecology.妇产科抗击新型冠状病毒肺炎的科研工作
Ultrasound Obstet Gynecol. 2021 Feb;57(2):189-194. doi: 10.1002/uog.23584.
4
d-Dimer and COVID-19.D-二聚体与新型冠状病毒肺炎
Radiology. 2020 Dec;297(3):E343-E344. doi: 10.1148/radiol.2020203481. Epub 2020 Oct 13.
5
[Antibiotic use in hospitals in cases of COVID-19].[新型冠状病毒肺炎病例在医院中的抗生素使用情况]
Tidsskr Nor Laegeforen. 2020 Jun 19;140(11). doi: 10.4045/tidsskr.20.0443. Print 2020 Aug 18.
6
Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.在美国中西部一家学术医疗中心，新冠病毒肺炎（COVID-19）患者中肌钙蛋白I升高与不良预后相关。
J Appl Lab Med. 2020 Sep 1;5(5):1137-1139. doi: 10.1093/jalm/jfaa092.
7
Anticoagulation in COVID-19.新型冠状病毒肺炎中的抗凝治疗
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):260-261. doi: 10.1093/ehjcvp/pvaa036.
8
Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?新型冠状病毒肺炎的患病率和死亡率：全球范围内差异巨大的原因是什么？
Travel Med Infect Dis. 2020 May-Jun;35:101711. doi: 10.1016/j.tmaid.2020.101711. Epub 2020 Apr 29.
9
Coronavirus disease 2019 and obstructive sleep apnea syndrome.2019冠状病毒病与阻塞性睡眠呼吸暂停综合征
Sleep Breath. 2021 Mar;25(1):371. doi: 10.1007/s11325-020-02087-0. Epub 2020 Apr 28.
10
Distinct Clinical Characteristics and Risk Factors for Mortality in Female Inpatients With Coronavirus Disease 2019 (COVID-19): A Sex-stratified, Large-scale Cohort Study in Wuhan, China.中国武汉一项性别分层的大规模队列研究：2019 年冠状病毒病（COVID-19）女性住院患者死亡的临床特征和危险因素分析。
Clin Infect Dis. 2020 Dec 15;71(12):3188-3195. doi: 10.1093/cid/ciaa920.

引用本文的文献

1
The Potential Risk of Reduced Serum Cholinesterase Activity in COVID-19 Patients Suffering From Cytokine Storm.细胞因子风暴的新冠肺炎患者血清胆碱酯酶活性降低的潜在风险
Cureus. 2024 May 16;16(5):e60417. doi: 10.7759/cureus.60417. eCollection 2024 May.
2
Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.新冠疫情在布朗克斯的蒙特菲奥里医疗系统爆发3.5年后新出现的肝脏疾病的发病率、特征及风险因素
PLoS One. 2024 Jun 13;19(6):e0303151. doi: 10.1371/journal.pone.0303151. eCollection 2024.
3
Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis.

本文引用的文献

1
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.《COVID-19 大流行期间肝病学和肝移植提供者的临床最佳实践建议：AASLD 专家小组共识声明》。
Hepatology. 2020 Jul;72(1):287-304. doi: 10.1002/hep.31281.
2
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素：基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
3
COVID-19 and the liver: little cause for concern.
慢性肾脏病及透析患者对SARS-CoV-2疫苗免疫反应的有效性和安全性：一项系统评价和荟萃分析
Biomed Rep. 2024 Mar 19;20(5):78. doi: 10.3892/br.2024.1766. eCollection 2024 May.
4
SARS-CoV-2 associated liver injury: a six-month follow-up analysis of liver function recovery.新型冠状病毒2型相关肝损伤：肝功能恢复的6个月随访分析
Med Pharm Rep. 2022 Oct;95(4):393-399. doi: 10.15386/mpr-2347. Epub 2022 Oct 27.
5
COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes.COVID-19 相关肝损伤：综合综述，特别考虑妊娠和产科结局。
World J Gastroenterol. 2022 Nov 14;28(42):6017-6033. doi: 10.3748/wjg.v28.i42.6017.
6
Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge.COVID-19 相关异常肝功能试验在出院后 2 个月恢复的临床预测因素。
Sci Rep. 2022 Oct 26;12(1):17972. doi: 10.1038/s41598-022-22741-9.
7
Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach.采用联合建模方法研究 COVID-19 住院患者肝损伤与炎症生物标志物的纵向关系。
Sci Rep. 2022 Apr 1;12(1):5547. doi: 10.1038/s41598-022-09290-x.
8
Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19.新型冠状病毒肺炎不同临床类型患者肝功能指标的动态变化
Int J Gen Med. 2022 Jan 26;15:877-884. doi: 10.2147/IJGM.S347291. eCollection 2022.
9
Liver injury with COVID-19: laboratory and histopathological outcome-systematic review and meta-analysis.新型冠状病毒肺炎相关肝损伤：实验室检查及组织病理学结果——系统评价与Meta分析
Egypt Liver J. 2022;12(1):9. doi: 10.1186/s43066-022-00171-6. Epub 2022 Jan 21.
10
The impact of the COVID pandemic on primary care diabetes services in the UK: A cross-sectional national survey of views of health professionals delivering diabetes care.新冠疫情对英国基层医疗糖尿病服务的影响：一项关于提供糖尿病护理的卫生专业人员观点的全国性横断面调查。
Prim Care Diabetes. 2022 Apr;16(2):257-263. doi: 10.1016/j.pcd.2021.12.015. Epub 2022 Jan 13.
新冠病毒与肝脏：无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
4
Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports.编辑关注——不同报告中可能存在对同一新冠患者的重复报告。
JAMA. 2020 Apr 7;323(13):1256. doi: 10.1001/jama.2020.3980.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
7
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
8
Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence.血清总骨钙素与 2 型糖尿病及中间代谢表型的关系：观察性证据的系统评价和荟萃分析。
Eur J Epidemiol. 2015 Aug;30(8):599-614. doi: 10.1007/s10654-015-0058-x. Epub 2015 Jun 18.